Targeting myostatin to improve skeletal muscle mass and function in a mouse model of Dnm2-related centronuclear myopathy

Anne Cécile Durieux (1) , David Arnould (1) , Valentine Allibert (1) , Cloé Paret (2, 3) , Pierre Pelliat , Esra Elmali , Josiane Castells (1) , Emmanuelle Girard (4, 5) , Christophe Hourde , Arja Pasternack (6) , Laurent Schaeffer , Marc Bitoun (7) , Olli Ritvos (8) , Rémi Mounier , Damien Freyssenet (1)

1 LIBM - Laboratoire Interuniversitaire de Biologie de la Motricité
2 INMG - Institut NeuroMyoGène
3 LBTI - Laboratoire de Biologie Tissulaire et d'ingénierie Thérapeutique UMR 5305
4 NBCM - Laboratoire de neurobiologie cellulaire et moléculaire
5 INAF - Institut de Neurobiologie Alfred Fessard
6 Department of Bacteriology and Immunology [Helsinki]
7 Centre de recherche en Myologie – U974 SU-INSERM
8 Faculty of Medicine - Department of Bacteriology and Immunology and Department of Physiology [Helsinki, Finland]

Domaines: Sciences du Vivant [q-bio]

Anne Cécile Durieux, David Arnould, Valentine Allibert, Cloé Paret, Pierre Pelliat, et al.. Targeting myostatin to improve skeletal muscle mass and function in a mouse model of Dnm2-related centronuclear myopathy. Journées de la Société Française de Myologie, Nov 2022, Toulouse, France. 2022. ⟨hal-03953238⟩